Cholesterol and Lipid Test Market Size and Share Forecast Outlook From 2024 to 2034

The global cholesterol and lipid test market size reached USD 2.7 billion in 2023 and is anticipated to expand at a 7.6% CAGR during the forecast period. Total market valuation is predicted to increase from USD 3.0 billion in 2024 to USD 6.2 billion by 2034.

Attributes Key Insights
Cholesterol and Lipid Test Market Value in 2023 USD 2.7 billion
Estimated Cholesterol and Lipid Test Market Value (2024E) USD 3.0 billion
Projected Cholesterol and Lipid Test Market Value (2034F) USD 6.2 billion
Expected Cholesterol and Lipid Test Market CAGR of (2024 to 2034) 7.6%
Market Share of Top 5 Countries 51.9%

Cholesterol and Lipid Test Market Overview

Cholesterol and lipid tests are becoming ideal means of monitoring and maintaining cholesterol levels in the body. These tests are set to help detect bad cholesterol or low-density lipoprotein (LDL) and different cardiovascular diseases.

High cholesterol levels often lead to atherosclerosis, narrowing the arteries and making it more difficult for blood to flow through the vessels. This can result in the development of cardiovascular illnesses. The rising need for atherosclerosis screening for early detection and treatment is expected to fuel sales of cholesterol and lipid test solutions.

A routine blood cholesterol test should be performed to ascertain the level of cholesterol accumulation. The recommended total cholesterol level is 200mg/dL or below (ATP III), according to the National Cholesterol Education Programme (NCEP) Third Adult Treatment Panel.

The NCEP suggests that triglyceride levels be less than 150 mg/dL, HDL levels above or equal to 40 mg/dL, and LDL levels less than 100 mg/dL. For this purpose, cholesterol and lipid tests are widely used.

Other factors influencing market growth include:

  • Growing need for advanced cardiovascular health testing solutions
  • Advancements in the cholesterol testing products & services market
  • Rising interest in preventive healthcare
  • Growing popularity of point-of-care testing (POCT)

Sales Trend Analysis from 2019 to 2023 Compared to Market Outlook for 2024 to 2034

The cholesterol and lipid test market expanded historically at a CAGR of 7.6% between 2019 and 2023. It attained a value of around USD 2.7 billion at the end of 2023.

In 2022, the cholesterol and lipid test market accounted for around 9.6% of the global rapid test market, valued at USD 28.5 billion. Over the forecast period, the global market for cholesterol and lipid tests is anticipated to expand at a CAGR of 7.6%.

Historical CAGR (2019 to 2023) 7.6%
Forecast CAGR (2024 to 2034) 7.6%

Cholesterol and lipid testing have been critical to cardiovascular disease management for several decades. The development of cholesterol testing began in the mid-20th century with the introduction of tests for total cholesterol levels.

The market for cholesterol and lipids tests is anticipated to expand as a result of the rising demand for over-the-counter cholesterol and lipids test kits and expanding electronic miniaturization. Subsequently, the rising popularity of preventive healthcare, the development of self-testing kits, and raising awareness about the importance of cholesterol level assessment will boost the market.

The aging population and the widespread adoption of the Western lifestyle in developing nations result in higher levels of atherogenic dyslipidemia and cholesterol. This is expected to fuel sales of cholesterol and lipid test products.

Cardiovascular diseases, including heart disease and strokes, remain a leading cause of mortality worldwide. The rising prevalence of these conditions and the growing awareness of the importance of cholesterol and lipid management are expected to drive the demand for cholesterol and lipids tests.

There is also a shift toward proactive healthcare and preventive measures to mitigate the risk of cardiovascular diseases. Cholesterol and lipid tests are crucial for identifying individuals at risk and guiding preventive strategies. The emphasis on preventive care is expected to fuel cholesterol and lipid test industry demand.

Lucrative Opportunities Driving Demand Growth in the Cholesterol and Lipid Test Market

Demand for early diagnosis and treatment is anticipated to increase rapidly. This is due to the increasing prevalence of cardiovascular illnesses and their risk factors, including diabetes and hypertension.

Regular cholesterol and lipids testing is necessary for patients with a history of heart attacks to assess how well their therapy is working. As a result, the cholesterol and lipid test market is anticipated to expand steadily throughout the forecast period due to the increasing incidence of cardiac illnesses.

There is a growing emphasis on preventive healthcare to address the burden of cardiovascular diseases. Cholesterol and lipids tests are essential for early detection, risk assessment, and monitoring of lipid profiles. The increasing adoption of preventive healthcare strategies opens up opportunities for the market.

Factors Restraining the Demand for Cholesterol and Lipid Testing Products

Long-term difficulties with cost, misinterpretation of the electronic result, and fasting before cholesterol testing could significantly limit the use of cholesterol and lipid tests during the forecast period. Similarly, the lack of LDL and HDL testing characteristics will restrain market growth.

Understanding the results of a handful of at-home cholesterol test kits can be challenging since they are tough to use. End-users might not get an accurate result if the tool is not used properly. It could be more expensive to get electronic testing kits or cholesterol test kits that check triglycerides, LDL, and HDL levels.

Certain cholesterol and lipid tests require end-users to send a blood sample to the laboratory for analysis. This can cost money and put users through weeks of waiting for results.

Analysis of Top Countries Diagnosing,Screening,Distributing,and Monitoring Cholesterol and Lipid Levels

The table below shows the anticipated growth rates of the top countries. India, Germany, and the United Kingdom are expected to record lucrative CAGRs of 8.4%, 7.6%, and 7.8%, respectively, through 2034.

Countries CAGR (2024 to 2034)
United States 6.4%
China 6.8%
United Kingdom 7.8%
Japan 6.5%
Germany 7.6%
India 8.4%

Rising Prevalence of Obesity Boosting the United States Market

The United States held a significant revenue share of about 90.6% of the North America cholesterol and lipid test market in 2023. The total cholesterol and lipid test market value in the United States reached USD 787.02 million at the end of 2023.

As per the latest report, demand for cholesterol and lipid tests in the United States is projected to rise at a 6.4% CAGR through 2034. This is attributable to the rising rates of obesity and heart disease in the United States and the increasing need for preventive healthcare.

There has been a sharp rise in the cases of obesity and other cardiovascular diseases in the United States during the last several years. For instance, as per the 2017 to 2018 National Health and Nutrition Examination Survey (NHANES), around 42% of the United States-based adults aged 20 and over had obesity.

Obesity and other cardiovascular diseases are often linked to high cholesterol levels. As a result, demand for cholesterol and lipid tests is expected to rise rapidly in the country. This is because these tests can help in the early detection and monitoring of CVD risk by providing accurate cholesterol level assessment.

The United States government and several organizations are increasing their efforts to raise public awareness about cardiovascular diseases, including their diagnosis and treatments. This will likely improve the United States cholesterol and lipid test market share through 2034.

Increasing Government Initiatives to Fuel Demand in Germany

Germany’s cholesterol and lipid test market value totaled USD 157.10 million in 2023. Over the forecast period, demand for cholesterol and lipid test products in Germany is predicted to rise at a 7.6% CAGR.

Multiple factors are expected to drive cholesterol and lipid test demand in Germany. These include increasing cases of cardiovascular diseases, rising need for lipoprotein measurement to detect the risk of cardiovascular diseases, and rising support from the government and other organizations.

The National Nutrition Society is a key player in Germany's effort to create clinical standards for treating cardiovascular disease. It has created new health promotion initiatives, especially in light of the nation’s growth in diabetes and obesity.

The new promotional strategies and policies will likely boost the adoption rate of cholesterol and lipid testing devices in the country. This will foster the growth of the cholesterol and lipid test market in Germany.

Advancements in Testing Technologies Fostering Growth in China

China dominated the East Asia cholesterol and lipid test market in 2023 with a share of about 45.3%. Total cholesterol and lipid test revenue in China reached USD 194.01 million at the end of 2023.

Over the forecast period, China’s cholesterol and lipid test industry size is projected to expand at a 6.8% CAGR. This is attributable to rising obesity rates across the country, advancements in cholesterol testing technologies, and the portability of electronics and their usefulness in the creation of self-testing kits.

Thanks to advancements in testing technologies, China-based companies are developing more convenient and accurate cholesterol and lipid testing methods. These include home testing kits, pint-of-care testing devices, and other advanced laboratory-based tests. This is expected to improve China's cholesterol and lipid test market share.

Rising Interest in Cholesterol Management to Boost the United Kingdom

The United Kingdom’s cholesterol and lipid test market size reached USD 137.09 million in 2023. For the projection period, a CAGR of 7.8% has been predicted for the United Kingdom’s cholesterol and lipid test industry.

Several factors are expected to boost the growth of the cholesterol and lipid test market in the United Kingdom. These include rising incidence of cholesterol and lipid disorder and rising awareness about the benefits of cholesterol & lipid management.

People across the United Kingdom are becoming aware of the importance of cholesterol and lipid management for preventing cardiovascular disorders. As a result, they are opting for different cholesterol and lipid tests, thereby fostering market growth.

Increasing Incidence of Cardiovascular Diseases Propelling Demand in India

India is emerging as a highly lucrative market for cholesterol and lipid testing products across South Asia. This is due to the rising incidence of cardiovascular disease, increasing government initiatives, and expanding healthcare infrastructure.

The cholesterol and lipid test market value in India totaled USD 79.74 million in 2023. Over the forecast period, demand for cholesterol and lipid tests in India is anticipated to rise at an 8.4% CAGR.

Growing demand for liquid profile diagnostics is another key factor expected to fuel sales of cholesterol and lipid test products. Subsequently, increasing emphasis on blood lipid analysis to determine the risk of developing cardiovascular disease will foster growth.

Cholesterol and Lipid Test Industry Analysis by Top Investment Segments

The section below shows the analyzer kits leading the cholesterol and lipid test market. It is poised to exhibit a CAGR of 7.4% during the forecast period. By test type, the total cholesterol test asthma segment is anticipated to thrive at 6.0% CAGR.

Based on application, the hyperlipidemia segment is expected to dominate the global cholesterol and lipid test industry. It will likely expand at 6.9% CAGR between 2024 and 2034. By end-user, the hospital segment is projected to register a CAGR of 7.5% through 2034.

Demand Remains High for Analyzer Kits Worldwide

Market Growth Outlook by Product

Product Value CAGR
Test Strip Kits 8.3%
Analyzer Kits 7.4%

Based on product, the analyzer kits segment generated a revenue of USD 1.9 billion in 2023. Over the assessment period, demand for analyzer kits is projected to rise at a CAGR of 7.4%. This is due to the rising usage of analyzer kits in a variety of settings, including hospitals, clinics, and diagnostic centers.

Advancements in analyzer kits will also drive growth of the target segment. Patients now have better access to cholesterol testing due to the development of cutting-edge testing kits.

High Prevalence of Cardiovascular Diseases Fueling Total Cholesterol Test Demand

Market Growth Outlook by Test Type

Test Type Value CAGR
Total Cholesterol Test 6.0%
HDL Cholesterol Test 7.1%
LDL Cholesterol Test 7.9%
Triglycerides/VLDL Cholesterol Test 8.7%
Others 9.0%

By test type, the total cholesterol test segment attained a valuation of USD 704.0 million in 2023. Over the forecast period, the target segment is anticipated to thrive at a healthy CAGR of 6.0%. It will likely retain its dominance throughout the assessment period.

Demand for total cholesterol tests is anticipated to increase due to the rising prevalence of cardiovascular illnesses and related risk factors, including diabetes and hypertension. Similarly, increasing the prevalence of high cholesterol and other related diseases will also boost the target segment.

Regular cholesterol testing is necessary for patients with a history of heart attacks to assess the efficacy of their medication. As a result, demand for total cholesterol tests is anticipated to rise significantly throughout the forecast period due to the rising prevalence of cardiac disorders.

Hyperlipidemia Remains a Key Revenue-generation Application

Market Growth Outlook by Application

Application Value CAGR
Hyperlipidemia 6.9%
Hypertriglyceridemia 8.0%
Hyperlipoproteinemia 8.5%
Tangier Disease 6.4%
Familial Hypercholesterolemia 7.5%
Others 8.8%

Based on application, the hyperlipidemia segment dominated the global cholesterol and lipid test market, holding a value share of about 25.9% in 2023. It will likely expand at a 6.9% CAGR through 2034. This is attributable to the rising prevalence of hyperlipidemia globally.

Poor dietary habits, characterized by high intake of saturated fats, trans fats, and cholesterol-rich foods, contribute to the development of hyperlipidemia. The rising incidence of this medical condition is expected to create demand for cholesterol and lipid tests.

Consuming foods such as red meat, full-fat dairy products, fried foods, and processed snacks can elevate cholesterol levels, especially low-density lipoprotein (LDL) cholesterol, commonly referred to as "bad" cholesterol. This will foster the growth of the target segment.

Hospitals Remain the Leading End-users of Cholesterol and Lipid Test Products

Market Growth Outlook by End-user

End-user Value CAGR
Clinics 6.8%
Hospitals 7.5%
Ambulatory Surgical Centers 8.3%
Homecare Settings 7.8%
Diagnostic Centers 7.2%

By end-users, the adoption of cholesterol and lipid test products remains high in hospitals. The target segment generated a revenue of about USD 765.5 million in 2023, holding 28.1% of the total market share.

For the assessment period, the hospitals segment is poised to exhibit a CAGR of 7.5%. This is due to the rising preference of people towards opting for cholesterol and lipid tests in hospitals due to lower costs.

Patients’ preference over choosing hospitals also includes factors such as disease severity, medical personnel availability, and availability of advanced machinery & better healthcare facilities. Hence, the hospital segment will continue to dominate the target market through 2034.

Leading Suppliers of Cholesterol and Lipid Testing Products

In recent years, leading players have introduced new technologies and products in the cholesterol and lipid test market. For example, Boditech Med introduced Ichorma LDL Cholesterol Direct in October 2021, and Ichroma AST secured export licenses. Both serve as warning signs for preventing lifestyle disorders, including arteriosclerosis, hypertension, diabetes, stroke, liver disease, etc.

Recent Developments in the Cholesterol and Lipid Test Market

  • In January 2022, CallonDoc released its at-home testing kits. By using these kits, users can check themselves for several ailments, including thyroid issues, STDs, diabetes, liver, kidney, and cholesterol issues.
  • In August 2019, the ‘CURO L7’ product was introduced by SD BIO. It is a home lipid cholesterol test kit that is FDA-approved and has features like an immediate blood profile in three minutes with several biomarker tests.

Top Segments Studied in the Cholesterol and Lipid Test Market Report

By Product:

  • Test Strip Kits
  • Analyzer Kits

By Test Type:

  • Total Cholesterol Test
  • HDL Cholesterol Test
  • LDL Cholesterol Test
  • Triglycerides/VLDL Cholesterol Test
  • Others

By Application:

  • Hyperlipidemia
  • Hypertriglyceridemia
  • Hyperlipoproteinemia
  • Tangier Disease
  • Familial Hypercholesterolemia
  • Others

By End-user:

  • Clinics
  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Trends & Dynamics
  • 4. Value-Added Insights
  • 5. Market Background
  • 6. Global Market Demand Volume (Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034
  • 7. Global Market - Pricing Analysis
  • 8. Global Market Demand (in Value or Size in USD billion) Analysis 2019 to 2023 and Forecast, 2024 to 2034
  • 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product
    • 9.1. Test Strip Kits
    • 9.2. Analyzer Kits
  • 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type
    • 10.1. Total Cholesterol Test
    • 10.2. HDL Cholesterol Test
    • 10.3. LDL Cholesterol Test
    • 10.4. Triglycerides/VLDL Cholesterol Test
    • 10.5. Other
  • 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application
    • 11.1. Hyperlipidemia
    • 11.2. Hypertriglyceridemia
    • 11.3. Hyperlipoproteinemia
    • 11.4. Tangier Disease
    • 11.5. Familial Hypercholesterolemia
    • 11.6. Others
  • 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
    • 12.1. Clinics
    • 12.2. Hospitals
    • 12.3. Ambulatory Surgical Centers
    • 12.4. Homecare Settings
    • 12.5. Diagnostic Centers
  • 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
    • 13.1. North America
    • 13.2. Latin America
    • 13.3. Europe
    • 13.4. South Asia
    • 13.5. East Asia
    • 13.6. Oceania
    • 13.7. Middle East & Africa
  • 14. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 15. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 16. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 17. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 18. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 19. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 20. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
  • 21. Market Structure Analysis
  • 22. Competition Analysis
    • 22.1. Boston Scientific Corporation
    • 22.2. Medtronic
    • 22.3. Koninklijke Philips N.V.
    • 22.4. F. Hoffmann-La Roche Ltd.
    • 22.5. Abbott
    • 22.6. AstraZeneca
    • 22.7. LivaNova PLC
    • 22.8. BIOTRONIK SE & Co. KG
    • 22.9. ACON Laboratories, Inc.
    • 22.10. Spectra Laboratories, Inc.
    • 22.11. Eurofins Scientific
    • 22.12. Randox Laboratories Ltd
    • 22.13. Quest Diagnostic
    • 22.14. Spectra Laboratories
  • 23. Assumptions and Acronyms Used
  • 24. Research Methodology

List of Tables

Table 01: Global Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 02: Global Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 03: Global Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 04: Global Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 05: Global Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

Table 06: North America Market Value (US$ billion) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country

Table 07: North America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 08: North America Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 09: North America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 10: North America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 11: North America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

Table 12: Latin America Market Value (US$ billion) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country

Table 13: Latin America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 14: Latin America Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 15: Latin America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 16: Latin America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 17: Latin America Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

Table 18: Europe Market Value (US$ billion) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country

Table 19: Europe Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 20: Europe Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 21: Europe Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 22: Europe Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 23: Europe Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

Table 24: East Asia Market Value (US$ billion) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country

Table 25: East Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 26: East Asia Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 27: East Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 28: East Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 29: East Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

Table 30: South Asia Market Value (US$ billion) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country

Table 31: South Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 32: South Asia Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 33: South Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 34: South Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 35: South Asia Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

Table 36: Oceania Market Value (US$ billion) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country

Table 37: Oceania Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 38: Oceania Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 39: Oceania Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 40: Oceania Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 41: Oceania Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

Table 42: United Kingdom Market Value (US$ billion) Analysis 2019 to 2023 and Forecast 2024 to 2034, by Country

Table 43: United Kingdom Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Product

Table 44: United Kingdom Market Volume (Units) Analysis and Forecast 2019 to 2034, by Product

Table 45: United Kingdom Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Test Type

Table 46: United Kingdom Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by Application

Table 47: United Kingdom Market Value (US$ billion) Analysis and Forecast 2019 to 2034, by End User

List of Figures

Figure 01: Global Market Volume (Units), 2019 to 2023

Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis,

Figure 03: Pricing Analysis per unit (US$), in 2024

Figure 04: Pricing Forecast per unit (US$), in 2034

Figure 05: Global Market Value (US$ billion) Analysis, 2019 to 2023

Figure 06: Global Market Forecast & Y-o-Y Growth, 2024 to 2034

Figure 07: Global Market Absolute $ Opportunity (US$ billion) Analysis, 2024 to 2034

Figure 08: Global Market Value Share (%) Analysis 2024 and 2034, by Product

Figure 09: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by Product

Figure 10: Global Market Attractiveness Analysis 2024 to 2034, by Product

Figure 11: Global Market Value Share (%) Analysis 2024 and 2034, by Test Type

Figure 12: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by Test Type

Figure 13: Global Market Attractiveness Analysis 2024 to 2034, by Test Type

Figure 14: Global Market Value Share (%) Analysis 2024 and 2034, by Application

Figure 15: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by Application

Figure 16: Global Market Attractiveness Analysis 2024 to 2034, by Application

Figure 17: Global Market Value Share (%) Analysis 2024 and 2034, by End User

Figure 18: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by End User

Figure 19: Global Market Attractiveness Analysis 2024 to 2034, by End User

Figure 20: Global Market Value Share (%) Analysis 2024 and 2034, by Region

Figure 21: Global Market Y-o-Y Growth (%) Analysis 2024 to 2034, by Region

Figure 22: Global Market Attractiveness Analysis 2024 to 2034, by Region

Figure 23: North America Market Value (US$ billion) Analysis, 2019 to 2023

Figure 24: North America Market Value (US$ billion) Forecast, 2024 to 2034

Figure 25: North America Market Value Share, by Product (2024 E)

Figure 26: North America Market Value Share, by Test Type (2024 E)

Figure 27: North America Market Value Share, by Application (2024 E)

Figure 28: North America Market Value Share, by End User (2024 E)

Figure 29: North America Market Value Share, by Country (2024 E)

Figure 30: North America Market Attractiveness Analysis by Product, 2024 to 2034

Figure 31: North America Market Attractiveness Analysis by Test Type, 2024 to 2034

Figure 32: North America Market Attractiveness Analysis by Application, 2024 to 2034

Figure 33: North America Market Attractiveness Analysis by End User, 2024 to 2034

Figure 34: North America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 35: United States Market Value Proportion Analysis, 2024

Figure 36: Global Vs. United States Growth Comparison

Figure 37: United States Market Share Analysis (%) by Product, 2024 to 2034

Figure 38: United States Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 39: United States Market Share Analysis (%) by Application, 2024 to 2034

Figure 40: United States Market Share Analysis (%) by End User, 2024 to 2034

Figure 41: Canada Market Value Proportion Analysis, 2024

Figure 42: Global Vs. Canada. Growth Comparison

Figure 43: Canada Market Share Analysis (%) by Product, 2024 to 2034

Figure 44: Canada Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 45: Canada Market Share Analysis (%) by Application, 2024 to 2034

Figure 46: Canada Market Share Analysis (%) by End User, 2024 to 2034

Figure 47: Latin America Market Value (US$ billion) Analysis, 2019 to 2023

Figure 48: Latin America Market Value (US$ billion) Forecast, 2024 to 2034

Figure 49: Latin America Market Value Share, by Product (2024 E)

Figure 50: Latin America Market Value Share, by Test Type (2024 E)

Figure 51: Latin America Market Value Share, by Application (2024 E)

Figure 52: Latin America Market Value Share, by End User (2024 E)

Figure 53: Latin America Market Value Share, by Country (2024 E)

Figure 54: Latin America Market Attractiveness Analysis by Product, 2024 to 2034

Figure 55: Latin America Market Attractiveness Analysis by Test Type, 2024 to 2034

Figure 56: Latin America Market Attractiveness Analysis by Application, 2024 to 2034

Figure 57: Latin America Market Attractiveness Analysis by End User, 2024 to 2034

Figure 58: Latin America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 59: Mexico Market Value Proportion Analysis, 2024

Figure 60: Global Vs Mexico Growth Comparison

Figure 61: Mexico Market Share Analysis (%) by Product, 2024 to 2034

Figure 62: Mexico Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 63: Mexico Market Share Analysis (%) by Application, 2024 to 2034

Figure 64: Mexico Market Share Analysis (%) by End User, 2024 to 2034

Figure 65: Brazil Market Value Proportion Analysis, 2024

Figure 66: Global Vs. Brazil. Growth Comparison

Figure 67: Brazil Market Share Analysis (%) by Product, 2024 to 2034

Figure 68: Brazil Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 69: Brazil Market Share Analysis (%) by Application, 2024 to 2034

Figure 70: Brazil Market Share Analysis (%) by End User, 2024 to 2034

Figure 71: Argentina Market Value Proportion Analysis, 2024

Figure 72: Global Vs Argentina Growth Comparison

Figure 73: Argentina Market Share Analysis (%) by Product, 2024 to 2034

Figure 74: Argentina Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 75: Argentina Market Share Analysis (%) by Application, 2024 to 2034

Figure 76: Argentina Market Share Analysis (%) by End User, 2024 to 2034

Figure 77: Europe Market Value (US$ billion) Analysis, 2019 to 2023

Figure 78: Europe Market Value (US$ billion) Forecast, 2024 to 2034

Figure 79: Europe Market Value Share, by Product (2024 E)

Figure 80: Europe Market Value Share, by Test Type (2024 E)

Figure 81: Europe Market Value Share, by Application (2024 E)

Figure 82: Europe Market Value Share, by End User (2024 E)

Figure 83: Europe Market Value Share, by Country (2024 E)

Figure 84: Europe Market Attractiveness Analysis by Product, 2024 to 2034

Figure 85: Europe Market Attractiveness Analysis by Test Type, 2024 to 2034

Figure 86: Europe Market Attractiveness Analysis by Application, 2024 to 2034

Figure 87: Europe Market Attractiveness Analysis by End User, 2024 to 2034

Figure 88: Europe Market Attractiveness Analysis by Country, 2024 to 2034

Figure 89: United Kingdom Market Value Proportion Analysis, 2024

Figure 90: Global Vs. United Kingdom Growth Comparison

Figure 91: United Kingdom Market Share Analysis (%) by Product, 2024 to 2034

Figure 92: United Kingdom Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 93: United Kingdom Market Share Analysis (%) by Application, 2024 to 2034

Figure 94: United Kingdom Market Share Analysis (%) by End User, 2024 to 2034

Figure 95: Germany Market Value Proportion Analysis, 2024

Figure 96: Global Vs. Germany Growth Comparison

Figure 97: Germany Market Share Analysis (%) by Product, 2024 to 2034

Figure 98: Germany Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 99: Germany Market Share Analysis (%) by Application, 2024 to 2034

Figure 100: Germany Market Share Analysis (%) by End User, 2024 to 2034

Figure 101: Italy Market Value Proportion Analysis, 2024

Figure 102: Global Vs. Italy Growth Comparison

Figure 103: Italy Market Share Analysis (%) by Product, 2024 to 2034

Figure 104: Italy Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 105: Italy Market Share Analysis (%) by Application, 2024 to 2034

Figure 106: Italy Market Share Analysis (%) by End User, 2024 to 2034

Figure 107: France Market Value Proportion Analysis, 2024

Figure 108: Global Vs France Growth Comparison

Figure 109: France Market Share Analysis (%) by Product, 2024 to 2034

Figure 110: France Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 111: France Market Share Analysis (%) by Application, 2024 to 2034

Figure 112: France Market Share Analysis (%) by End User, 2024 to 2034

Figure 113: Spain Market Value Proportion Analysis, 2024

Figure 114: Global Vs Spain Growth Comparison

Figure 115: Spain Market Share Analysis (%) by Product, 2024 to 2034

Figure 116: Spain Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 117: Spain Market Share Analysis (%) by Application, 2024 to 2034

Figure 118: Spain Market Share Analysis (%) by End User, 2024 to 2034

Figure 119: Russia Market Value Proportion Analysis, 2024

Figure 120: Global Vs Russia Growth Comparison

Figure 121: Russia Market Share Analysis (%) by Product, 2024 to 2034

Figure 122: Russia Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 123: Russia Market Share Analysis (%) by Application, 2024 to 2034

Figure 124: Russia Market Share Analysis (%) by End User, 2024 to 2034

Figure 125: BENELUX Market Value Proportion Analysis, 2024

Figure 126: Global Vs BENELUX Growth Comparison

Figure 127: BENELUX Market Share Analysis (%) by Product, 2024 to 2034

Figure 128: BENELUX Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 129: BENELUX Market Share Analysis (%) by Application, 2024 to 2034

Figure 130: BENELUX Market Share Analysis (%) by End User, 2024 to 2034

Figure 131: East Asia Market Value (US$ billion) Analysis, 2019 to 2023

Figure 132: East Asia Market Value (US$ billion) Forecast, 2024 to 2034

Figure 133: East Asia Market Value Share, by Product (2024 E)

Figure 134: East Asia Market Value Share, by Test Type (2024 E)

Figure 135: East Asia Market Value Share, by Application (2024 E)

Figure 136: East Asia Market Value Share, by End User (2024 E)

Figure 137: East Asia Market Value Share, by Country (2024 E)

Figure 138: East Asia Market Attractiveness Analysis by Product, 2024 to 2034

Figure 139: East Asia Market Attractiveness Analysis by Test Type, 2024 to 2034

Figure 140: East Asia Market Attractiveness Analysis by Application, 2024 to 2034

Figure 141: East Asia Market Attractiveness Analysis by End User, 2024 to 2034

Figure 142: East Asia Market Attractiveness Analysis by Country, 2024 to 2034

Figure 143: China Market Value Proportion Analysis, 2024

Figure 144: Global Vs. China Growth Comparison

Figure 145: China Market Share Analysis (%) by Product, 2024 to 2034

Figure 146: China Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 147: China Market Share Analysis (%) by Application, 2024 to 2034

Figure 148: China Market Share Analysis (%) by End User, 2024 to 2034

Figure 149: Japan Market Value Proportion Analysis, 2024

Figure 150: Global Vs. Japan Growth Comparison

Figure 151: Japan Market Share Analysis (%) by Product, 2024 to 2034

Figure 152: Japan Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 153: Japan Market Share Analysis (%) by Application, 2024 to 2034

Figure 154: Japan Market Share Analysis (%) by End User, 2024 to 2034

Figure 155: South Korea Market Value Proportion Analysis, 2024

Figure 156: Global Vs South Korea Growth Comparison

Figure 157: South Korea Market Share Analysis (%) by Product, 2024 to 2034

Figure 158: South Korea Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 159: South Korea Market Share Analysis (%) by Application, 2024 to 2034

Figure 160: South Korea Market Share Analysis (%) by End User, 2024 to 2034

Figure 161: South Asia Market Value (US$ billion) Analysis, 2019 to 2023

Figure 162: South Asia Market Value (US$ billion) Forecast, 2024 to 2034

Figure 163: South Asia Market Value Share, by Product (2024 E)

Figure 164: South Asia Market Value Share, by Test Type (2024 E)

Figure 165: South Asia Market Value Share, by Application (2024 E)

Figure 166: South Asia Market Value Share, by End User (2024 E)

Figure 167: South Asia Market Value Share, by Country (2024 E)

Figure 168: South Asia Market Attractiveness Analysis by Product, 2024 to 2034

Figure 169: South Asia Market Attractiveness Analysis by Test Type, 2024 to 2034

Figure 170: South Asia Market Attractiveness Analysis by Application, 2024 to 2034

Figure 171: South Asia Market Attractiveness Analysis by End User, 2024 to 2034

Figure 172: South Asia Market Attractiveness Analysis by Country, 2024 to 2034

Figure 173: India Market Value Proportion Analysis, 2024

Figure 174: Global Vs. India Growth Comparison

Figure 175: India Market Share Analysis (%) by Product, 2024 to 2034

Figure 176: India Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 177: India Market Share Analysis (%) by Application, 2024 to 2034

Figure 178: India Market Share Analysis (%) by End User, 2024 to 2034

Figure 179: Indonesia Market Value Proportion Analysis, 2024

Figure 180: Global Vs. Indonesia Growth Comparison

Figure 181: Indonesia Market Share Analysis (%) by Product, 2024 to 2034

Figure 182: Indonesia Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 183: Indonesia Market Share Analysis (%) by Application, 2024 to 2034

Figure 184: Indonesia Market Share Analysis (%) by End User, 2024 to 2034

Figure 185: Malaysia Market Value Proportion Analysis, 2024

Figure 186: Global Vs. Malaysia Growth Comparison

Figure 187: Malaysia Market Share Analysis (%) by Product, 2024 to 2034

Figure 188: Malaysia Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 189: Malaysia Market Share Analysis (%) by Application, 2024 to 2034

Figure 190: Malaysia Market Share Analysis (%) by End User, 2024 to 2034

Figure 191: Thailand Market Value Proportion Analysis, 2024

Figure 192: Global Vs. Thailand Growth Comparison

Figure 193: Thailand Market Share Analysis (%) by Product, 2024 to 2034

Figure 194: Thailand Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 195: Thailand Market Share Analysis (%) by Application, 2024 to 2034

Figure 196: Thailand Market Share Analysis (%) by End User, 2024 to 2034

Figure 197: Oceania Market Value (US$ billion) Analysis, 2019 to 2023

Figure 198: Oceania Market Value (US$ billion) Forecast, 2024 to 2034

Figure 199: Oceania Market Value Share, by Product (2024 E)

Figure 200: Oceania Market Value Share, by Test Type (2024 E)

Figure 201: Oceania Market Value Share, by Application (2024 E)

Figure 202: Oceania Market Value Share, by End User (2024 E)

Figure 203: Oceania Market Value Share, by Country (2024 E)

Figure 204: Oceania Market Attractiveness Analysis by Product, 2024 to 2034

Figure 205: Oceania Market Attractiveness Analysis by Test Type, 2024 to 2034

Figure 206: Oceania Market Attractiveness Analysis by Application, 2024 to 2034

Figure 207: Oceania Market Attractiveness Analysis by End User, 2024 to 2034

Figure 208: Oceania Market Attractiveness Analysis by Country, 2024 to 2034

Figure 209: Australia Market Value Proportion Analysis, 2024

Figure 210: Global Vs. Australia Growth Comparison

Figure 211: Australia Market Share Analysis (%) by Product, 2024 to 2034

Figure 212: Australia Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 213: Australia Market Share Analysis (%) by Application, 2024 to 2034

Figure 214: Australia Market Share Analysis (%) by End User, 2024 to 2034

Figure 215: New Zealand Market Value Proportion Analysis, 2024

Figure 216: Global Vs New Zealand Growth Comparison

Figure 217: New Zealand Market Share Analysis (%) by Product, 2024 to 2034

Figure 218: New Zealand Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 219: New Zealand Market Share Analysis (%) by Application, 2024 to 2034

Figure 220: New Zealand Market Share Analysis (%) by End User, 2024 to 2034

Figure 221: Middle East & Africa Market Value (US$ billion) Analysis, 2019 to 2023

Figure 222: Middle East & Africa Market Value (US$ billion) Forecast, 2024 to 2034

Figure 223: Middle East & Africa Market Value Share, by Product (2024 E)

Figure 224: Middle East & Africa Market Value Share, by Test Type (2024 E)

Figure 225: Middle East & Africa Market Value Share, by Application (2024 E)

Figure 226: Middle East & Africa Market Value Share, by End User (2024 E)

Figure 227: Middle East & Africa Market Value Share, by Country (2024 E)

Figure 228: Middle East & Africa Market Attractiveness Analysis by Product, 2024 to 2034

Figure 229: Middle East & Africa Market Attractiveness Analysis by Test Type, 2024 to 2034

Figure 230: Middle East & Africa Market Attractiveness Analysis by Application, 2024 to 2034

Figure 231: Middle East & Africa Market Attractiveness Analysis by End User, 2024 to 2034

Figure 232: Middle East & Africa Market Attractiveness Analysis by Country, 2024 to 2034

Figure 233: GCC Countries Market Value Proportion Analysis, 2024

Figure 234: Global Vs GCC Countries Growth Comparison

Figure 235: GCC Countries Market Share Analysis (%) by Product, 2024 to 2034

Figure 236: GCC Countries Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 237: GCC Countries Market Share Analysis (%) by Application, 2024 to 2034

Figure 238: GCC Countries Market Share Analysis (%) by End User, 2024 to 2034

Figure 239: Türkiye Market Value Proportion Analysis, 2024

Figure 240: Global Vs. Türkiye Growth Comparison

Figure 241: Türkiye Market Share Analysis (%) by Product, 2024 to 2034

Figure 242: Türkiye Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 243: Türkiye Market Share Analysis (%) by Application, 2024 to 2034

Figure 244: Türkiye Market Share Analysis (%) by End User, 2024 to 2034

Figure 245: South Africa Market Value Proportion Analysis, 2024

Figure 246: Global Vs. South Africa Growth Comparison

Figure 247: South Africa Market Share Analysis (%) by Product, 2024 to 2034

Figure 248: South Africa Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 249: South Africa Market Share Analysis (%) by Application, 2024 to 2034

Figure 250: South Africa Market Share Analysis (%) by End User, 2024 to 2034

Figure 251: North Africa Market Value Proportion Analysis, 2024

Figure 252: Global Vs North Africa Growth Comparison

Figure 253: North Africa Market Share Analysis (%) by Product, 2024 to 2034

Figure 254: North Africa Market Share Analysis (%) by Test Type, 2024 to 2034

Figure 255: North Africa Market Share Analysis (%) by Application, 2024 to 2034

Figure 256: North Africa Market Share Analysis (%) by End User, 2024 to 2034

Frequently Asked Questions

How big is the cholesterol and lipid test market?

The global cholesterol and lipid test market value totaled USD 2.7 billion in 2023.

What is the demand outlook for cholesterol and lipid tests?

Demand for cholesterol and lipid tests is expected to expand at a 7.6% CAGR.

What is the expected cholesterol and lipid test market size in 2034?

By 2034, the market size is set to reach USD 6.2 billion.

Who are the top players in the cholesterol and lipid test market?

Abbott Laboratories, AstraZeneca, LivaNova, and Boston Scientific Corporation.

Which are the top 5 countries driving demand for cholesterol and lipid tests?

Germany, the United States, China, Japan, and the United Kingdom.

How big is the North America cholesterol and lipid test market?

North America held a market share of 31.9% in 2023.

What are the key factors driving the cholesterol and lipid test industry?

Technology advancement in tests and rising prevalence of obesity.

What is the demand outlook for Europe's cholesterol and lipid test market?

Demand in Europe is expected to rise at 8.4% CAGR through 2034.

How much does a lipid cholesterol test cost?

It costs around 320 to 250 rupees in India.

What is the test for cholesterol for lipids?

A blood test is used to measure levels of cholesterol and other fats in blood.

What is the cost of a cholesterol lipid profile?

Cholesterol lipid profile test price varies from 340 to 1000 in India.

Explore Similar Insights

Future Market Insights

Cholesterol and Lipid Test Market